Health Condition 1: null- Vitiligo Health Condition 2: L80- Vitiligo
Conditions
Interventions
Intervention1: UNIM- 001 and UNIM â?? 003: UNIM-001 given orally and
UNIM003 given for topical application
Duration of treatment is 8 months
Dose(mg) of UNIM001 /T
3200mg/day in the form of tab b.i.
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with clinically diagnosed non-segmental generalized Vitiligo 2. Subjects with 18 -50 years of age. 3. Either gender 4. Willingness to give written informed consent form.
Exclusion criteria
Exclusion criteria: Vitiligo Subjects with treatment with other drugs/systems 2. Non-cooperative subjects 3. H/o of drug or alcohol abuse, smokers 4. Any clinically significant abnormality identified on physical examination or laboratory tests 5. Subjects having any systemic disease and other skin diseases. 6. Subjects with known allergies 7. Impaired Cardiac, Hepatic and Renal function 8. History of malignancy 9. History of hypersensitivity to any of the investigational drugs / herbal medicine. 11. Receiving any other investigational product from minimum last 4 weeks. 12. Any medical condition, where physician feels participation in the study could be detrimental to subjects well being. 13. Uncontrolled infection 14. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Comparison of biomarker levels between normal control and Vitiligo patients 2. Change in the status of biomarker level before and after the treatment with Unani formulation Timepoint: 8 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Study of co-relation of level of biomarkers with the degree of disease condition of VitiligoTimepoint: 8 months | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed